Inventor · disambiguated record
Roger Aston
Also filed as: ASTON ROGER
35 granted patents·40 pending applications·1,561 citations·filing 1988–2022
98Inventor score
Files withPEPTECH LTD8PSIMEDICA LTD8PITNEY PHARMACEUTICALS PTY LTD7ARANA THERAPEUTICS LTD5PEPTIDE TECHNOLOGY LTD4
Top patents by PatentIndex Score
75 records- 0198US6593458B1Tumor necrosis factor peptide binding antibodiesPEPTECH LTD·Filed 2000·Granted Jul 15, 2003·176 cites·1 claims
- 0298US6498237B2Tumor necrosis factor antibodiesPEPTECH LTD·Filed 2000·Granted Dec 24, 2002·199 cites·48 claims
- 0398US6451983B2Tumor necrosis factor antibodiesPEPTECH LTD·Filed 2000·Granted Sep 17, 2002·206 cites·50 claims
- 0498US6448380B2Tumor necrosis factor antibodiesPEPTECH LTD·Filed 2000·Granted Sep 10, 2002·209 cites·48 claims
- 0597US5959087ATumour necrosis factor binding ligandsPEPTIDE TECHNOLOGY LTD·Filed 1997·Granted Sep 28, 1999·135 cites·4 claims
- 0696US7517963B2Tumour necrosis factor binding ligandsARANA THERAPEUTICS LTD·Filed 2006·Granted Apr 14, 2009·16 cites·118 claims
- 0793US7528237B2Tumour necrosis factor binding ligandsARANA THERAPEUTICS LTD·Filed 2007·Granted May 5, 2009·7 cites·158 claims
- 0893US6929950B2Microprojectile delivery system and particulate productPSIMEDICA LTD·Filed 2001·Granted Aug 16, 2005·39 cites·10 claims
- 0991US7553641B2Tumour necrosis factor binding ligandsARANA THERAPEUTICS LTD·Filed 2007·Granted Jun 30, 2009·4 cites·188 claims
- 1091US6416757B1Tumor necrosis factor antibodiesPEPTIDE TECHNOLOGY LTD·Filed 1999·Granted Jul 9, 2002·39 cites·50 claims
- 1190US8128912B2Method of protecting skin from UV radiation using a dermatological composition having porous siliconCANHAM LEIGH T·Filed 2005·Granted Mar 6, 2012·13 cites·7 claims
- 1290US8097236B2Devices and methods for the treatment of cancerASTON ROGER·Filed 2002·Granted Jan 17, 2012·30 cites·5 claims
- 1390US5644034ATumour necrosis factor binding ligandsPEPTIDE TECHNOLOGY LTD·Filed 1994·Granted Jul 1, 1997·91 cites·7 claims
- 1487US7544782B2Tumour necrosis factor binding ligandsARANA THERAPEUTICS LTD·Filed 2006·Granted Jun 9, 2009·4 cites·100 claims
- 1586US8647603B2Devices and methods for the treatment of cancerASTON ROGER·Filed 2011·Granted Feb 11, 2014·6 cites·18 claims
- 1686US7186267B2Porous and/or polycrystalline silicon orthopaedic implantPSIMEDICA LTD·Filed 2001·Granted Mar 6, 2007·51 cites·2 claims
- 1786US5045312APhysiologically active compositions of growth hormone and serum albumin or Ig GBURROUGHS WELLCOME CO·Filed 1988·Granted Sep 3, 1991·105 cites·9 claims
- 1885US5534492AMuramyl peptide for the treatment of toxicityPEPTECH UK LTD·Filed 1993·Granted Jul 9, 1996·82 cites·23 claims
- 1982US10053422B2Compounds for the treatment of mTOR pathway related diseasesPITNEY PHARMACEUTICALS PTY LTD·Filed 2017·Granted Aug 21, 2018·4 cites·19 claims
- 2081US7294406B2Medical fibres and fabricsPSIMEDICA LTD·Filed 2002·Granted Nov 13, 2007·17 cites·12 claims
- 2177US7605233B2Tumour necrosis factor binding ligandsARANA THERAPEUTICS LTD·Filed 2007·Granted Oct 20, 2009·2 cites·130 claims
- 2277US5756449APeptide T and related peptides in the treatment of inflammation, including inflammatory bowel diseasePEPTIDE TECHNOLOGY LTD·Filed 1993·Granted May 26, 1998·63 cites·18 claims
- 2372US2010125130A1Tumour necrosis factor binding ligandsRATHJEN DEBORAH ANN·Filed 2009·Application pending·0 cites
- 2471US9907778B2Anticancer agent comprising aminoacetonitrile compound as active ingredientPITNEY PHARMACEUTICALS PTY LTD·Filed 2014·Granted Mar 6, 2018·2 cites·12 claims
- 2570US5506204AMuramyl compounds for treatment of septic shockPEPTECH UK LTD·Filed 1992·Granted Apr 9, 1996·23 cites·8 claims
- 2670US2006140951A1Tumour necrosis factor binding ligandsRATHJEN DEBORAH A·Filed 2006·Application pending·0 cites
- 2769US9790176B2Compounds for the treatment of mTOR pathway related diseasesPITNEY PHARMACEUTICALS PTY LTD·Filed 2013·Granted Oct 17, 2017·1 cites·13 claims
- 2869US2020206372A1Devices and methods for the treatment of cancerONCOSIL MEDICAL LTD·Filed 2019·Application pending·0 cites
- 2968US2003216552A1Tumour necrosis factor peptide binding antibodiesFiled 2003·Application pending·0 cites
- 3068US2004002589A1Tumour necrosis factor peptide binding antibodiesFiled 2003·Application pending·0 cites
- 3168US2003171555A1Tumour necrosis factor peptide binding antibodiesFiled 2003·Application pending·0 cites
- 3268US2004092721A1Tumour necrosis factor peptide binding antibodiesFiled 2003·Application pending·0 cites
- 3368US2008260839A1Pulmonary FormulationPSIMEDICA LTD·Filed 2008·Application pending·0 cites
- 3468US2003166874A1Tumour necrosis factor peptide binding antibodiesFiled 2003·Application pending·0 cites
- 3568US2004002590A1Tumour necrosis factor peptide binding antibodiesFiled 2003·Application pending·0 cites
- 3668US2004126376A1Tumour necrosis factor binding ligandsFiled 2003·Application pending·0 cites
- 3768US2003208047A1Tumour necrosis factor peptide binding antibodiesFiled 2003·Application pending·0 cites
- 3868US2003171554A1Tumour necrosis factor peptide binding antibodiesFiled 2003·Application pending·0 cites
- 3967US9833431B2Pharmaceutical combinations for the treatment of cancerPITNEY PHARMACEUTICALS PTY LTD·Filed 2014·Granted Dec 5, 2017·1 cites·14 claims
- 4067US2003162948A1Tumour necrosis factor binding ligandsFiled 2002·Application pending·0 cites
- 4167US2003199678A1Tumour necrosis factor binding ligandsFiled 2002·Application pending·0 cites
- 4267US2006159677A1Tumour necrosis factor peptide binding antibodiesPEPTECH LTD·Filed 2006·Application pending·0 cites
- 4367US2004002588A1Tumour necrosis factor binding ligandsFiled 2002·Application pending·0 cites
- 4467US2003139580A1Tumour necrosis factor binding ligandsFiled 2002·Application pending·0 cites
- 4567US2003170204A1Tumour necrosis factor binding ligandsFiled 2002·Application pending·0 cites
- 4667US2004214993A2Tumour necrosis factor binding ligandsRATHJEN DEBORAH·Filed 2002·Application pending·0 cites
- 4766US11369666B2Treatment of diseases involving mucinNEWSOUTH INNOVATIONS PTY LTD·Filed 2013·Granted Jun 28, 2022·1 cites·16 claims
- 4866US11364286B2Compositions and methods for the treatment of diseases involving mucinNEWSOUTH INNOVATIONS PTY LTD·Filed 2016·Granted Jun 21, 2022·1 cites·13 claims
- 4966US2006140952A1Tumour necrosis factor binding ligandsRATHJEN DEBORAH A·Filed 2006·Application pending·0 cites
- 5066US2006233802A1Tumour necrosis factor binding ligandsPEPTECH LTD·Filed 2006·Application pending·0 cites
Showing the top 50 of 75 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Roger Aston files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →